Walled Lake Planning & Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Walled Lake Planning & Wealth Management's BMY Position: Q4 2020 in Review
Walled Lake Planning & Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 164 shares — an estimated $10K sold.
Walled Lake Planning & Wealth Management first reported a position in BMY in Q2 2020 and held it in 2 quarters. The position peaked at $10K in Q3 2020. 2,362 funds tracked by Wall St. Rank hold BMY as of Q4 2020.
- Walled Lake Planning & Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
- Walled Lake Planning & Wealth Management sold 164 Bristol-Myers Squibb shares in Q4 2020, an estimated $10K.
- Walled Lake Planning & Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 2 quarters.
- Walled Lake Planning & Wealth Management's Bristol-Myers Squibb position peaked at $10K in Q3 2020.
- 2,362 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.
Based on Walled Lake Planning & Wealth Management's 13F filing for Q4 2020, filed 19 Feb 2021.